In Genome Technology a year ago, our cover story featured what we call “next-generation genomics” — a series of marketplace applications in which genomics has already made a mainstream appearance. Those areas included anti-counterfeiting measures, personalized skin care, and improved artificial flavors, among others. In the year since, those organizations have continued to make strides; genetically personalized skin care products, for one, have been prominently featured in consumer media.
In our news section last year, we introduced you to Shamrock Structures, a protein crystallography company based in Woodridge, Ill., led by CEO Steve Schiltz. Last November, the company announced a deal to provide structural proteomics services — including crystallization, synchrotron data collection, and protein structure determination — to the Seattle-based Trubion Pharmaceuticals.
Another news story highlighted a talk by Mike Metzker from Baylor about a “suitcase sequencer” technology under development in his lab. Metzker presented the work again at this year’s Advances in Genome Biology and Technology conference, indicating progress that had been made in the design of the four-laser machine. Meanwhile, he says, that work has led to related research on an imaging technology for high-density arrays.